Page 14 - Journal of Structural Heart Disease Volume 3, Issue 4
P. 14
101
Original Research Article
8. Doguet F, Leguillou V, Godin M. Infected amplatzer device. J Card Surg. 2011;26:75. DOI: 10.1111/j.1540-8191.2010.01139.x
9. Zahr F, Katz WE, Toyoda Y, Anderson WD. Late bacterial endocarditis of an amplatzer atrial septal defect occluder device. Am J Cardiol. 2010;105:279-280. DOI: 10.1016/j. amjcard.2009.09.011
10. Calachanis M, Carrieri L, Grimaldi R, Veg- lio F, Orzan F. Infective endocarditis after transcatheter closure of a patent fora- men ovale. Catheter Cardiovasc Interv. 2004;63:351-354. DOI: 10.1002/ccd.20185
11. Sohail MR, Henrikson CA, Jo Braid-Forbes M, Forbes KF, Lerner DJ. Increased long- term mortality in patients with cardio- vascular implantable electronic device infections. Pacing Clin Electrophysiol. 2015;38:231-239. DOI: 10.1111/pace.12518
12. de Bie MK, van Rees JB, Thijssen J, Borle s CJ, Trines SA, Cannegieter SC, et al. Cardiac de- vice infections are associated with a signi - cant mortality risk. Heart Rhythm. 2012;9:494- 498. DOI: 10.1016/j.hrthm.2011.10.034
13. Kearney RA, Eisen HJ, Wolf JE. Nonvalvular infections of the cardiovascular system. Ann Intern Med. 1994;121:219-230. PMID: 8017749
14. Thanavaro KL, Nixon JV. Endocarditis 2014: An update. Heart Lung. 2014;43:334-337. DOI: 10.1016/j.hrtlng.2014.03.009
15. Tomomasa R, Yamashiro K, Tanaka R, Hat- tori N. Cerebral infarction in an HIV-in- fected patient with combined protein S and C de ciency and a patent fora- men ovale. J Stroke Cerebrovasc Dis. 2013;22:e650-c652. DOI: 10.1016/j.jstroke- cerebrovasdis.2013.04.019
16. Bushnell CD, Goldstein LB. Diagnostic test- ing for coagulopathies in patients with ischemic stroke. Stroke. 2000;31:3067- 3078. PMID: 11108774
17. Dodge SM, Hassell K, Anderson CA, Keller J, Groves B, Carroll JD. Antiphospholip- id antibodies are common in patients referred for percutaneous patent foramen ovale closure. Catheter Cardiovasc Interv. 2004;61:123-127. DOI: 10.1002/ccd.10754
18. Tanaka Y, Ueno Y, Miyamoto N, Shimada Y, Tanaka R, Hattori N, et al. Patent foramen ovale and atrial septal aneurysm can cause ischemic stroke in patients with antiphos- pholipid syndrome. J Neurol. 2013;260:189- 196. DOI: 10.1007/s00415-012-6613-4
19. Rajamani K, Chaturvedi S, Jin Z, Homma S, Brey RL, Tilley BC, et al. Patent foramen ovale, cardiac valve thickening, and anti- phospholipid antibodies as risk factors for subsequent vascular events: The PICSS- APASS study. Stroke. 2009;40:2337-2342. DOI: 10.1161/STROKEAHA.108.539171
Kar, S. et al.
PFO/ASD Closure in Compromised Patients
Cite this article as: Kar S, Aboulhosn J, Tandar A, Gevorgyan R, Miller N, Tobis J. Percutaneous Atrial Septal Closure in Immunocompromised Patients. Structural Heart Disease. 2017;3(4):96-101. DOI: https://doi. org/10.12945/j.jshd.2017.001.17
